Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...

A SYSTEMATIC review investigating the impact of glucagon-like peptide-1 receptor agonists on alcohol consumption has yielded ...

GLP-1 drugs such as Ozempic and Mounjaro have been heralded as some of the most important drug breakthroughs ever . This has ...

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.

Tom Nolan reviews this week’s research Many people with osteoporosis are unable to tolerate oral bisphosphonates—many others would prefer a six monthly denosumab injection to a once weekly pill that ...

Shalini’s obesity problem Shalini*, a 61-year-old woman is at the pinnacle of her career. She immigrated from India when she ...

MariTide Demonstrated up to ~20% Average Weight Loss at 52 Weeks Without a Weight Loss Plateau in People Living With Obesity or Overweight ...

WHILE the price of the same medication may be expensive in one pharmacy and very cheap in another, it may not be as a result ...

The myth of ‘big-boned’ continues to this day, leading to many unhealthy habits, practices, and lifestyles among the ...

Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...